Copyright
©The Author(s) 2003.
World J Gastroenterol. Apr 15, 2003; 9(4): 858-861
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.858
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.858
Type | NE Positive Case | Serotonin Case (%) | Somatostatin Case (%) | Glucagon Case (%) | P P Case (%) | Gastrin Case (%) | Calcitonin Case (%) | ACTH Case (%) |
Colorectal | 54 | 30 (55.6) | 14 (25.9) | 11 (20.4) | 5 (9.3) | 1 (1.9) | 0 | 0 |
carcinomas | ||||||||
Gastric | 38 | 5 (13.2) | 5 (13.2) | 5 (13.2) | 0 | 3 (7.9) | 0 | 6 (15.8) |
carcinomas | ||||||||
Pancreatic | 5 | 1 (20.0) | 0 | 1 (20.0) | 2 (40.0) | 0 | 0 | 0 |
Carcinomas | ||||||||
Breast | 17 | 1 (5.9) | 1 (5.9) | 0 | 0 | 0 | 1 (5.9) | 0 |
Carcinomas | ||||||||
Prostatic | 8 | 4 (50.0) | 0 | 2 (25.0) | 0 | 0 | 0 | 0 |
Carcinomas |
- Citation: Yao GY, Zhou JL, Lai MD, Chen XQ, Chen PH. Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol 2003; 9(4): 858-861
- URL: https://www.wjgnet.com/1007-9327/full/v9/i4/858.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i4.858